Sevelamer hydrochloride
NDC 70748-173, Sevelamer hydrochloride, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-173
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213145
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SEVELAMER HYDROCHLORIDE800 mg/1
Pharmacologic classes
Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-173-26 | 70748017326 | 180 TABLET in 1 BOTTLE (70748-173-26) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a56c857e-bc39-484c-908d-f5957857efbbNADAC price for package 70748017326
GET /v1/drugs/nadac/70748017326
Use it
Look up 70748-173 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.